VistaGen Therapeutics (VTGN)

• Market cap: $122M
• 1 day: -0.75%
• 5 days: -5.9%
• 1 month: 0.76%
• 3 months: 46.15%
• 6 months: 84.72%
• Year to date: 20.18%
• 1 year: 27.88%
• 5 years: -80.78%
• 10 years: -96.76%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 57